
|Articles|September 15, 2002
Retinal endovascular surgery helps those with CRVO, HRVO
Fort Lauderdale, FL-Vitrectomy with retinal vein cannulation and infusion of tissue plasminogen activator (t-PA) is a relatively safe procedure that improves vision in patients with central retinal vein occlusion (CRVO) or hemispheric retinal vein occlusion (HRVO), according to Jeffrey N. Weiss, MD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Ocumetics reports first-in-human data investigational accommodating IOL in severe vision loss
2
Metformin use associated with reduced incidence of intermediate AMD
3
EnVision Summit 2026: Ultimate gathering place for ophthalmic education
4
Sandoz Canada launches aflibercept biosimilar, Enzeevum
5




























